Clinical Trials Sponsored by Pharmexa-Epimmune
Total 6882 results
-
MedImmune LLCTerminated
-
MedImmune LLCTerminatedLymphomaUnited States, Poland
-
MedImmune LLCCompleted
-
MedImmune LLCCompleted
-
MedImmune LLCCompleted
-
MedImmune LLCWithdrawnBreast CancerUnited States
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedPsoriasisUnited States, Canada
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedAcute Myeloid Leukemia | LeukemiaUnited States, Israel
-
MedImmune LLCCompletedGraft Versus Host DiseaseUnited States
-
MedImmune LLCCompleted
-
MedImmune LLCCompleted
-
MedImmune LLCWithdrawnLymphoma, B-Cell | Lymphoma, Non-Hodgkin
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedProstate CancerUnited States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
-
MedImmune LLCCompletedPlaque PsoriasisUnited States, Canada
-
MedImmune LLCRecruitingAdvanced Renal Cell CarcinomaUnited States, Spain, France, Australia
-
MedImmune LLCActive, not recruitingUnresectable Pleural or Peritoneal Malignant MesotheliomaUnited States, Italy, Spain, United Kingdom, Belgium, Canada, Poland, France, Korea, Republic of, Hungary, Russian Federation, Germany, Australia, South Africa, Netherlands, Romania, Sweden, Israel, Denmark
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
MedImmune LLCCompletedCarcinoma | Metastatic Pancreatic AdenocarcinomaUnited States, Spain, Australia, Norway
-
MedImmune LLCCompletedSolid TumorsUnited States, Korea, Republic of, Australia
-
MedImmune LLCCompletedObesity | Diabetes Mellitus, Type IIUnited Kingdom
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Adimmune CorporationCompleted
-
MedImmune LLCCompletedNSCLC | Resectable | Early-stageUnited States, Canada, Switzerland, Italy, France, Portugal, Spain
-
MedImmune LLCCompletedRespiratory Syncytial Virus Prophylaxis
-
MedImmune LLCCompleted
-
MedImmune LLCCompletedCardiovascular Disease | AtherosclerosisUnited States
-
MedImmune LLCCompletedGastric or Gastroesophageal Junction AdenocarcinomaCanada, United States, Taiwan, Korea, Republic of, Japan, Singapore
-
MedImmune LLCCompletedLeukemia, Hairy CellItaly, Spain, United States, Belgium, Poland, Czechia, Germany, Serbia, United Kingdom, France, Israel, Ireland, Canada, Norway
-
MedImmune LLCCompletedType 2 Diabetes MellitusUnited States
-
MedImmune LLCCompletedAcute Myeloid Leukemia | Multiple Myeloma | Diffuse Large B-cell LymphomaUnited States, France, Korea, Republic of
-
MedImmune LLCCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC) | Small Cell Lung Cancer (SCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC) | Non Small Cell Lung Cancer Squamous (NSCLC-Sq)United States, Canada
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
Regimmune CorporationCompletedGraft Versus Host DiseaseUnited States
-
Adimmune CorporationCompleted
-
MedImmune LLCCompletedHealthy Subjects | SafetyUnited States, United Kingdom
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
MedImmune LLCCompletedHealthy Subjects | SafetyUnited States
-
MedImmune LLCCompletedCardiovascular Disease | AtherosclerosisUnited States
-
MedImmune LLCCompletedMultiple Sclerosis, Relapsing FormsUnited States, Spain, Poland, Ukraine
-
Adimmune CorporationCompleted
-
Adimmune CorporationCompleted
-
MedImmune LLCCompletedInfluenzaUnited States, South Africa
-
MedImmune LLCCompletedHealthy or Stable Underlying Chronic Medical ConditionUnited States
-
MedImmune LLCCompletedRenal InsufficiencyNew Zealand, Germany
-
MedImmune LLCCompletedHealthy VolunteersUnited States